These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7634832)

  • 1. Chronic activation of the immune system in HIV infection: contribution to T cell apoptosis and V beta selective T cell anergy.
    Gougeon ML
    Curr Top Microbiol Immunol; 1995; 200():177-93. PubMed ID: 7634832
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?
    Meyaard L; Schuitemaker H; Miedema F
    Immunol Today; 1993 Apr; 14(4):161-4. PubMed ID: 8098942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T cell receptor V beta repertoire in HIV-1 infection and disease.
    Soudeyns H; Rebai N; Pantaleo GP; Ciurli C; Boghossian T; Sékaly RP; Fauci AS
    Semin Immunol; 1993 Jun; 5(3):175-85. PubMed ID: 8102262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential priming to programmed cell death of superantigen-reactive lymphocytes of HIV patients.
    Gorla R; Imberti L; Prati E; Brugnoni D; Caligaris S; Cattaneo R; Albertini A; Primi D
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1097-103. PubMed ID: 7826697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed cell death in AIDS-related HIV and SIV infections.
    Gougeon ML; Garcia S; Heeney J; Tschopp R; Lecoeur H; Guetard D; Rame V; Dauguet C; Montagnier L
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):553-63. PubMed ID: 8102239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.
    Gougeon ML; Lecoeur H; Boudet F; Ledru E; Marzabal S; Boullier S; Roué R; Nagata S; Heeney J
    J Immunol; 1997 Mar; 158(6):2964-76. PubMed ID: 9058836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell apoptosis as a consequence of chronic activation of the immune system in HIV infection.
    Gougeon ML
    Adv Exp Med Biol; 1995; 374():121-7. PubMed ID: 7572386
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamics of T cell responses in HIV infection.
    Appay V; Papagno L; Spina CA; Hansasuta P; King A; Jones L; Ogg GS; Little S; McMichael AJ; Richman DD; Rowland-Jones SL
    J Immunol; 2002 Apr; 168(7):3660-6. PubMed ID: 11907132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
    Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
    Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells.
    Kameoka M; Suzuki S; Kimura T; Fujinaga K; Auwanit W; Luftig RB; Ikuta K
    Int Immunol; 1997 Oct; 9(10):1453-62. PubMed ID: 9352350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.
    Heeney J; Jonker R; Koornstra W; Dubbes R; Niphuis H; Di Rienzo AM; Gougeon ML; Montagnier L
    J Med Primatol; 1993; 22(2-3):194-200. PubMed ID: 8105093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell response to staphylococcal superantigens by asymptomatic HIV-infected individuals exhibits selective changes in T cell receptor V beta-chain usage.
    Bisset LR; Opravil M; Ludwig E; Fierz W
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):241-6. PubMed ID: 8471314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of anergy to the superantigen Staphylococcus enterotoxin B.
    Dannecker G; Schultz H; Mecheri S; Sappler G; Clarke K; Niethammer D; Hoffmann MK
    Immunodeficiency; 1993; 4(1-4):137-9. PubMed ID: 8167688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo.
    Heeg K; Gaus H; Griese D; Bendigs S; Miethke T; Wagner H
    Int Immunol; 1995 Jan; 7(1):105-14. PubMed ID: 7718507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients.
    Ramzaoui S; Jouen-Beades F; Michot F; Borsa-Lebas F; Humbert G; Tron F
    Clin Exp Immunol; 1995 Feb; 99(2):182-8. PubMed ID: 7851009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
    Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
    Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewing of the T-cell receptor repertoire in the lung of patients with HIV-1 infection.
    Trentin L; Zambello R; Facco M; Sancetta R; Cerutti A; Milani A; Tassinari C; Crivellaro C; Cipriani A; Agostini C; Semenzato G
    AIDS; 1996 Jun; 10(7):729-37. PubMed ID: 8805863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of apoptosis in HIV-infected humans and chimpanzees: relation with lymphocyte activation.
    Gougeon ML; Lecoeur H; Heeney J; Boudet F
    Immunol Lett; 1996 Jun; 51(1-2):75-81. PubMed ID: 8811348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigen as a modifying factor in HIV infection.
    Kobayashi N; Urasawa S
    Pediatr AIDS HIV Infect; 1996 Jun; 7(3):143-54. PubMed ID: 11361581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp120-induced programmed cell death in recently activated T cells without subsequent ligation of the T cell receptor.
    Foster S; Beverley P; Aspinall R
    Eur J Immunol; 1995 Jun; 25(6):1778-82. PubMed ID: 7615007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.